Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
Circulation. Genomic and Precision Medicine|March 27, 2026
Structural Evaluation of RYR2-CPVT Missense Variants and Continuous Bayesian Estimates of Their PenetranceKundivy Dauda, Kohei Yamauchi, Matthew Ku, et al.Stem Cell Reports|May 10, 2023
Cellular and electrophysiological characterization of triadin knockout syndrome using induced pluripotent stem cell-derived cardiomyocytesDaniel J Clemens, Dan Ye, Lili Wang, et al.Circulation|October 5, 2019
Cardiomyocyte Homeodomain-Interacting Protein Kinase 2 Maintains Basal Cardiac Function via Extracellular Signal-Regulated Kinase SignalingYuanjun Guo, Jennifer Y Sui, Kyungsoo Kim, et al.The Journal of Physiology|April 11, 2016
Computational cardiology and risk stratification for sudden cardiac death: one of the grand challenges for cardiology in the 21st centuryAdam P Hill, Matthew D Perry, Najah Abi-Gerges, et al.Circulation Research|October 5, 2017
Thyroid and Glucocorticoid Hormones Promote Functional T-Tubule Development in Human-Induced Pluripotent Stem Cell-Derived CardiomyocytesShan S Parikh, Daniel J Blackwell, Nieves Gomez-Hurtado, et al.Journal of the American Heart Association|October 31, 2019
Antagonism of the Thromboxane-Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular DystrophyJames D West, Cristi L Galindo, Kyungsoo Kim, et al.Journal of the American Heart Association|November 4, 2016
Contrasting Nav1.8 Activity in Scn10a-/- Ventricular Myocytes and the Intact HeartDina Myers Stroud, Tao Yang, Kevin Bersell, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 4, 2019
Two pools of IRE1α in cardiac and skeletal muscle cellsQian Wang, Jody Groenendyk, Tautvydas Paskevicius, et al.JCI Insight|January 6, 2022
The Purkinje-myocardial junction is the anatomic origin of ventricular arrhythmia in CPVTDaniel J Blackwell, Michela Faggioni, Matthew J Wleklinski, et al.Cardiovascular Research|January 19, 2024
Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium-glucose cotransporter 2 inhibitorsPaul J M Wijnker, Rafeeh Dinani, Nico C van der Laan, et al.Pageof 8